SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-003462
Filing Date
2021-03-25
Accepted
2021-03-25 09:18:24
Documents
91
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K crvs-20201231x10k.htm   iXBRL 10-K 3106793
2 EX-4.5 crvs-20201231xex4d5.htm EX-4.5 41430
3 EX-21.1 crvs-20201231xex21d1.htm EX-21.1 6228
4 EX-23.1 crvs-20201231xex23d1.htm EX-23.1 1997
5 EX-31.1 crvs-20201231xex31d1.htm EX-31.1 14249
6 EX-31.2 crvs-20201231xex31d2.htm EX-31.2 14648
7 EX-32.1 crvs-20201231xex32d1.htm EX-32.1 7419
8 GRAPHIC crvs-20201231x10k007.jpg GRAPHIC 76792
9 GRAPHIC crvs-20201231x10k008.jpg GRAPHIC 34494
10 GRAPHIC crvs-20201231x10k009.jpg GRAPHIC 65453
11 GRAPHIC crvs-20201231x10k010.jpg GRAPHIC 36351
  Complete submission text file 0001558370-21-003462.txt   11403593

Data Files

Seq Description Document Type Size
12 EX-101.SCH crvs-20201231.xsd EX-101.SCH 60851
13 EX-101.CAL crvs-20201231_cal.xml EX-101.CAL 65945
14 EX-101.DEF crvs-20201231_def.xml EX-101.DEF 202164
15 EX-101.LAB crvs-20201231_lab.xml EX-101.LAB 577343
16 EX-101.PRE crvs-20201231_pre.xml EX-101.PRE 408956
17 EXTRACTED XBRL INSTANCE DOCUMENT crvs-20201231x10k_htm.xml XML 2122710
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37719 | Film No.: 21770339
SIC: 2834 Pharmaceutical Preparations